GPhA opposes H.R. 5629, biologics bill
Generic Pharmaceutical Association issues statement on H.R. 5629 biologics bill
Generic Pharmaceutical Association President/CEO Kathleen Jaeger issued a statement on the introduction this week of H.R. 5629, the "Pathway to Biosimilars Act." The
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Recent Videos
